STEVE ASELAGE

CIK 1221599 · Chief Executive Officer · last filed 2024-06-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$17.93M

Companies

7

Total Filings

114

Lifetime Open-Market Net

-$21.13M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCRX Director 72,659 $8.70 $632.1K $65.1K 23 2024-06-14
Acer Therapeutics Inc. (ACER) Delisted Director 483,741 $0.66 $319.3K $696.7K 9 2023-03-16
TVTX Director 166,419 $52.04 $8.66M -$4.97M 12 2022-05-12
Travere Therapeutics, Inc. (RTRX) Delisted Director 233,732 -$3.46M 32 2020-11-06
Acer Therapeutics Inc. (ACERW) Delisted Director 13,905 $24.0K 2 2017-12-18
Acer Therapeutics Inc. (OPXAW) Delisted Director 11,905 $0 1 2017-09-21
BMRN EVP, Chief Business Officer 154,375 $55.95 $8.64M -$13.49M 33 2012-07-05

Recent Filings · Page 12 of 12

114 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2007-08-14 BMRN Mixed -$262.2K EDGAR
2007-06-12 BMRN Grant (A) $0 EDGAR
2007-05-02 BMRN Buy (P) +2,066 $14.3K EDGAR
2007-02-16 BMRN Mixed -$192.6K EDGAR
Showing 111114 of 114
Page 12 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.